V3254
Vitamin B12-Agarose
saline suspension
Synonym(s):
Cyanocobalamin-Agarose
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
Pricing and availability is not currently available.
form
saline suspension
Quality Level
extent of labeling
≥0.3 mg per mL
matrix
4% beaded agarose
matrix activation
cyanogen bromide
matrix attachment
carboxyl
matrix spacer
8 atoms
storage temp.
2-8°C
Physical form
Suspension in 0.5 M NaCl containing preservative
1 of 1
This Item | |||
|---|---|---|---|
| form saline suspension | form lyophilized powder | form powder | form powder |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| matrix attachment carboxyl | matrix attachment amino | matrix attachment - | matrix attachment - |
| extent of labeling ≥0.3 mg per mL | extent of labeling 2-6 μmol per mL gel | extent of labeling - | extent of labeling - |
| matrix spacer 8 atoms | matrix spacer 1 atom | matrix spacer - | matrix spacer - |
| storage temp. 2-8°C | storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C |
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Adam Schaffner et al.
Cell research, 29(4), 313-329 (2019-03-13)
Missense mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) cause the majority of familial and some sporadic forms of Parkinson's disease (PD). The hyperactivity of LRRK2 kinase induced by the pathogenic mutations underlies neurotoxicity, promoting the development of LRRK2 kinase inhibitors
Global Trade Item Number
| SKU | GTIN |
|---|---|
| V3254-5ML | 04061838197634 |
| V3254-25ML | 04061838197627 |